# Antiinflammatoric and Antioxidative Effect of Melatonin in Human Endotoxaemia

> **NCT01087359** · PHASE4 · COMPLETED · sponsor: **Herlev Hospital** · enrollment: 12 (estimated)

## Conditions studied

- Human Endotoxaemia

## Interventions

- **DRUG:** Melatonin

## Key facts

- **NCT ID:** NCT01087359
- **Lead sponsor:** Herlev Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-06
- **Primary completion:** 2011-01
- **Final completion:** 2011-02
- **Target enrollment:** 12 (ESTIMATED)
- **Last updated:** 2011-06-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01087359

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01087359, "Antiinflammatoric and Antioxidative Effect of Melatonin in Human Endotoxaemia". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01087359. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*